Legend Biotech Corp Proceeds From Borrowings Classified As Financing Activities
Legend Biotech Corp (LEGN) reported Proceeds From Borrowings Classified As Financing Activities of $2.87 million for the 12-month period ending 2019-12-31, per its 20-F/A filed 2023-02-17.
Discontinued › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2023-02-17
| Period end | Proceeds From Borrowings Classified As Financing Activities 12 month |
|---|---|
| 2019-12-31 | $2.87M 20-F/A · filed 2023-02-17 |